Tag Archives: TAG

Petition asks BRICS to triple TB R&D funding

By on .

Global tuberculosis treatment advocates and activists are asking leaders of the five countries that are home to almost half of all tuberculosis illnesses and deaths to triple their funding for research and development of new medicines and technologies to prevent, diagnose, and treat the leading infectious disease killer worldwide, on a petition that will be […]

TB advocates call on organizations, leaders to work together, speed access to existing treatments for drug resistant tuberculosis

By on .

They would like an answer on March 24 When World TB Day next Tuesday commemorates the discovery in 1882 of the bacteria that causes the disease, announcements and op-ed pieces will note the progress that has been made since, and will certainly call for more. A group of 89 organizations that last week sent a […]

TAG’s TB drug guide aims to equip activists

By on .

While the impact of tuberculosis grew over the last decades of the 20th century, with drug resistant forms of the disease and HIV fueling its spread and slowing cures, the drugs used to treat TB have not changed. Bedaquiline and delaminid are the only new TB drugs to have been approved in over forty years, […]

Hepatitis resolution passed by 67th World Health Assembly includes calls for increased access to new medicine, syringe exchange

By on .

Committing the World Health Organization and member states of the United Nations to efforts to combat to hepatitis worldwide, the 67th World Health Assembly today passed a Hepatitis Resolution that includes calls to use legal flexibilities to lower prices of new effective medicines, and accelerate harm reduction programs for people who inject drugs. The resolution […]

TB drug approvals, distribution deal inches options forward, but MDR TB treatment access still uncertain where needed most

By on .

Last week’s developments in TB treatment included the announcement that bedaquiline, the currently most promising medicine for multi-drug-resistant tuberculosis, will become available to patients in 130 low- and middle-income countries through the Stop TB Partnership’s Global Drug Facility. That good news for multidrug-resistant TB patients, many of whom have run out of other options, was […]

Tuberculosis drug maker Sanofi drops price, easing access to shortened TB infection treatment

By on .

It was Christmas come early for publicly funded TB programs and for advocates of improved tuberculosis regimens when the maker of a rifapentine, a drug that can shorten treatment for tuberculosis infection from as much as nine months to three months announced Thursday it will drop its price for the medicine to a dollar a […]

TB treatment advocates to Sanofi pharmaceutical company on drug price: “We cry enough!”

By on .

A little more than four months ago, a collection of organizations and individuals concerned with the high price of rifapentine, a drug that could treat tuberculosis more quickly than other drugs, and also treat TB infection before it caused illness, wrote to Sanofi, the company that makes the medicine. Noting that government funding that had […]

Towards Zero Deaths: Roadmap for Childhood Tuberculosis builds on proven steps

By on .

For years the most helpless victims of tuberculosis have also been the least noticed, although they are estimated to comprise up to 10 percent — or more, as they often go uncounted as well — of people sick with the disease worldwide. They are children, younger that 15 years old, whose lives are taken when […]

Brief: Flat funding of biomedical research costs lives, slows progress, hurts economy, and diminishes America’s leadership

By on .

A decade-long trend of diminished investment in medical research, exacerbated by budget-standoff driven “sequester” cuts are showing immediate and long term impacts: in stymieing promising studies, and in thwarting the development of the next generation of scientists, according to a brief from amfAR, the Foundation for AIDS Research and TAG, Treatment Action Group. The brief […]

Pipeline Report: Speed development of, access to products that will address global health needs

By on .

Imagine a world in which a single once-daily pill that can be taken without food, has few if any side effects, and can control the virus that leads to AIDS, is available, equally, to everyone who needs it. Imagine if governments and health systems all over the world were ready to make use of new […]